FDA Import Refusal AEK-0397756-6/11/1 — BOEHRINGER INGELHEIM
The FDA refused shipment AEK-0397756-6/11/1 from BOEHRINGER INGELHEIM (Mexico) on Feb 16, 2022. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 16, 2022
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75